Literature DB >> 7374776

Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour.

A R Green, J F Deakin.   

Abstract

When rats are given a series of electroconvulsive shocks (ECSs) over several days, they display enhanced behavioural responses to both serotonin- and dopamine-receptor agonists. Because these changes are seen when the ECS is given in ways closely mimicking the clinical administration of electroconvulsive therapy (ECT), it has been suggested that the changes in postsynaptic monoamine function may be involved in the antidepressant mechanisms of ECT. Ligand-binding studies have excluded the possibility that ECS alters the characteristics of either the serotonin or dopamine receptor; ECS may therefore be acting on neuronal systems which modulate monoamine neurotransmission. As repeated ECS has recently been reported to decrease both noradrenaline (NA)-sensitive adenylate cyclase and beta-adrenoreceptor binding, we have examined here whether changes in NA function are related to the effects of ECS on the serotonin- and dopamine-mediated behaviours. We demonstrate that although selective depletion of NA does not alter the drug-induced serotonin- and dopamine-mediated responses, it abolishes the ECS-induced enhancement of these behaviours.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7374776     DOI: 10.1038/285232a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  12 in total

Review 1.  Antidepressants and serotonergic neurotransmission: an integrative review.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 2.  Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.

Authors:  G B Baker; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

3.  Regional neurotransmitter responses after acute and chronic electroconvulsive shock.

Authors:  P Glue; M J Costello; A Pert; A Mele; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Electroconvulsive shock does not modify striatal contents of dopamine in MPTP-treated mice.

Authors:  E Garcia; J Sotelo
Journal:  Neurochem Res       Date:  1993-05       Impact factor: 3.996

5.  Repeated treatment with antidepressant drugs increases the behavioural response to apomorphine.

Authors:  J Maj; Z Rogóz; G Skuza; H Sowińska
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

6.  The serotonin/noradrenaline-link in brain. I. The role of noradrenaline and serotonin in the regulation of density and function of beta adrenoceptors and its alteration by desipramine.

Authors:  D H Manier; D D Gillespie; E Sanders-Bush; F Sulser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-02       Impact factor: 3.000

7.  Changes in noradrenergic neuroendocrine responses following repeated seizures and the mechanism of action of ECT.

Authors:  J R McWilliam; B S Meldrum; S A Checkley
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain.

Authors:  A Reches; H R Wagner; A I Barkai; V Jackson; E Yablonskaya-Alter; S Fahn
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment.

Authors:  A I Barkai; S Kowalik; A Reches
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamine- and dopamine-mediated behaviours and 5-HT2 receptor number in frontal cortex.

Authors:  A R Green; D J Heal; P Johnson; B E Laurence; V L Nimgaonkar
Journal:  Br J Pharmacol       Date:  1983-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.